Novartis Cosentyx gets USFDA approval Ruchika Sharma26 Dec 2021 9:45 AM ISTBasel: Novartis has announced the US Food and Drug Administration (USFDA) has approved Cosentyx (secukinumab) for the treatment of active...
Working on pan-coronavirus oral treatment: Novartis CEO Ruchika Sharma7 Dec 2021 2:46 PM ISTNew Delhi: Novartis hopes to still play a role in the development of COVID-19 treatments with research ongoing for a pill that could work broadly...
Delhi HC restrains 4 pharma firms from making, selling 2 Novartis patent drugs Roshni Dhar10 Nov 2021 12:24 AM ISTIn a major relief to Novartis, the Delhi High Court has restrained various generic pharmaceutical companies from manufacturing or selling Valsartan...
Health Bulletin 8 / November /2021 Roshni Dhar8 Nov 2021 4:53 PM ISTHere are Top Health Stories of the day Patient Dies Post Delivery Due to Heavy Bleeding: Consumer Court Slaps Hospital, Gynecologist, Surgeon with ...
Novartis, Dunad Therapeutics ink USD 1.3 billion protein degradation deal Ruchika Sharma4 Nov 2021 9:00 AM ISTCambridge: Dunad Therapeutics has recently announced that the company has entered a strategic collaboration and license agreement with Novartis to...
HC restrains 4 pharma firms from making, selling Novartis Sacubitril, Valsartan tablets Ruchika Sharma2 Nov 2021 6:09 PM ISTNew Delhi: In a major relief to Novartis, the Delhi High Court has restrained various generic pharmaceutical companies from manufacturing or...
Novartis Scemblix gets USFDA nod for chronic myeloid leukemia Ruchika Sharma31 Oct 2021 10:00 AM ISTBasel: Novartis has recently announced that the US Food and Drug Administration (FDA) has approved Scemblix (asciminib) for the treatment of chronic...
Setback: Novartis lung cancer drug fails phase 3 study CANOPY-1 Ruchika Sharma26 Oct 2021 10:00 AM ISTBasel: Novartis has announced that the CANOPY-1 Phase III study did not demonstrate the statistically significant primary endpoints of overall...
Novartis, BioNTech ink pact to support fill, finish of mRNA Pfizer-BioNTech COVID vaccine Ruchika Sharma22 Oct 2021 2:54 PM ISTBasel: Novartis has announced that the company has signed an initial agreement to leverage its manufacturing capacity and capabilities to address the...
Novartis LNA043 for knee osteoarthritis gets USFDA fast track status Ruchika Sharma5 Sept 2021 10:15 AM ISTLNA043 is a ANGPTL3 agonist that targets damaged cartilage and modulates several pathways involved in cartilage regeneration.
Novartis pediatric psoriasis treatment Cosentyx approved in China Ruchika Sharma18 Aug 2021 3:46 PM ISTBasel: Novartis has recently announced that the China National Medical Products Administration (NMPA) has further approved Cosentyx (secukinumab) for...
Novartis gets CDSCO Committee nod to Xolair to treat rhinosinusitis with nasal polyps Medical Dialogues Team17 March 2021 9:15 AM ISTNew Delhi: Subject Expert Committee (SEC) functional under Central Drugs Standard Control Organization (CDSCO) has granted permission to Novartis...
